Literature DB >> 2157666

Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1.

M P Kolotila1, R D Diamond.   

Abstract

The relationship to pathogenesis of the spontaneous phenotypic switching of Candida albicans is uncertain. Since neutrophils are critical in containment of disseminated candidiasis, we used these cells and some of their potentially microbicidal oxidative products to define effects on a C. albicans strain (WO-1) that exhibits characteristic, easily recognized switching between the white and opaque phenotypes. Blastoconidia of the opaque phenotypes were more susceptible than those of the white to killing by either intact neutrophils or cell-free oxidants, including reagent hydrogen peroxide or the myeloperoxidase-H2O2-Cl- system. Paralleling these findings, opaque blastoconidia were 2.8- to 3.6-fold more potent stimuli of neutrophil superoxide generation than were the white cells. In addition, both neutrophils and oxidants (reagent H2O2 or hypochlorous acid as well as the myeloperoxidase-H2O2-Cl- system) induced unidirectional increases in spontaneous rates of switching from white to opaque phenotypes. Differences in expression of C. albicans phenotypes therefore may determine relative susceptibility to neutrophil fungicidal mechanisms, and neutrophils themselves appear to be capable of selectively augmenting the switching process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157666      PMCID: PMC258606          DOI: 10.1128/iai.58.5.1174-1179.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

2.  Oxidation of reduced cytochrome c by hydrogen peroxide. Implications for superoxide assays.

Authors:  P L Vandewalle; N O Petersen
Journal:  FEBS Lett       Date:  1987-01-05       Impact factor: 4.124

3.  "White-opaque transition": a second high-frequency switching system in Candida albicans.

Authors:  B Slutsky; M Staebell; J Anderson; L Risen; M Pfaller; D R Soll
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

4.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

5.  Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro.

Authors:  R D Diamond; R A Clark; C C Haudenschild
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  Assessment of chlorination by human neutrophils.

Authors:  C S Foote; T E Goyne; R I Lehrer
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

7.  High-frequency switching of colony morphology in Candida albicans.

Authors:  B Slutsky; J Buffo; D R Soll
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

8.  Zinc and regulation of growth and phenotype in the infectious yeast Candida albicans.

Authors:  D R Soll; G W Bedell; M Brummel
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant.

Authors:  F Macdonald; F C Odds
Journal:  J Gen Microbiol       Date:  1983-02

10.  Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis.

Authors:  F Macdonald; F C Odds
Journal:  J Med Microbiol       Date:  1980-08       Impact factor: 2.472

View more
  45 in total

1.  Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.

Authors:  C Kvaal; S A Lachke; T Srikantha; K Daniels; J McCoy; D R Soll
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans.

Authors:  T Srikantha; L Tsai; K Daniels; A J Klar; D R Soll
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

3.  Hemoglobin regulates expression of an activator of mating-type locus alpha genes in Candida albicans.

Authors:  Michael L Pendrak; S Steve Yan; David D Roberts
Journal:  Eukaryot Cell       Date:  2004-06

Review 4.  High-frequency switching in Candida albicans.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

5.  Stress-induced phenotypic switching in Candida albicans.

Authors:  Kevin Alby; Richard J Bennett
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

Review 6.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

7.  A MADS box protein consensus binding site is necessary and sufficient for activation of the opaque-phase-specific gene OP4 of Candida albicans.

Authors:  S R Lockhart; M Nguyen; T Srikantha; D R Soll
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

8.  Misexpression of the white-phase-specific gene WH11 in the opaque phase of Candida albicans affects switching and virulence.

Authors:  C A Kvaal; T Srikantha; D R Soll
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 9.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections.

Authors:  K W Deitsch; E R Moxon; T E Wellems
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

10.  Phenotypic switching of Candida guilliermondii is associated with pseudohyphae formation and antifungal resistance.

Authors:  Eglė Lastauskienė; Jolita Čeputytė; Irutė Girkontaitė; Auksė Zinkevičienė
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.